Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP266848.RAXlyMVf_CSD5v054QSoVu6lhVmzCC_dZ-RpZilPElak0130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266848.RAXlyMVf_CSD5v054QSoVu6lhVmzCC_dZ-RpZilPElak0130_provenance.
• NP210996.RA-8dNpJ9-L4FKcXtTtjVEd0A0rS9TOTNqau7dEdqKAM8130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP210996.RA-8dNpJ9-L4FKcXtTtjVEd0A0rS9TOTNqau7dEdqKAM8130_provenance.
• NP709167.RAh98nUIc9kgTbU8ayy0CQ2x1uj2yUKvfhNhjWRH29yGI130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709167.RAh98nUIc9kgTbU8ayy0CQ2x1uj2yUKvfhNhjWRH29yGI130_provenance.
• assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP467622.RAXSNtk3WnBa4ZMaEy-oTmGQjDcRug2duYk37X61Kl9S0130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP467622.RAXSNtk3WnBa4ZMaEy-oTmGQjDcRug2duYk37X61Kl9S0130_provenance.
• NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_provenance.
• assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_provenance.
• NP346870.RAXEHC7qydPXkFddTm5UWPVcEU7EeJIDlru9WEOIKqlJM130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346870.RAXEHC7qydPXkFddTm5UWPVcEU7EeJIDlru9WEOIKqlJM130_provenance.
• NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_provenance.
• NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_provenance.
• NP346902.RAvyXqwprT0cM-wSgARF829yVoWuObLEWqQ5-6arj9gNc130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346902.RAvyXqwprT0cM-wSgARF829yVoWuObLEWqQ5-6arj9gNc130_provenance.
• NP680399.RAqjYW4ZQUuUGlPWIgJgqM7P0xtjJ5QZqxdiX9bLdrSNA130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680399.RAqjYW4ZQUuUGlPWIgJgqM7P0xtjJ5QZqxdiX9bLdrSNA130_provenance.
• NP267590.RA13ZTGixdrXc-Fp511ncedWRe_MmwyAbxeSsf0he0-As130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP267590.RA13ZTGixdrXc-Fp511ncedWRe_MmwyAbxeSsf0he0-As130_provenance.
• NP680398.RAzLPjKkNNHZ2iTrdS8J1ryvwA33r2xOTMpDglGNIKBqI130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680398.RAzLPjKkNNHZ2iTrdS8J1ryvwA33r2xOTMpDglGNIKBqI130_provenance.
• NP680403.RA3_jSagfccMC-6Njs8VdPQQTBmrGaz1l4_Fp0A0Dseio130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680403.RA3_jSagfccMC-6Njs8VdPQQTBmrGaz1l4_Fp0A0Dseio130_provenance.